Pulmonary Neuroendocrine Tumor
📧 Sign up to get email alerts when something new happens for Pulmonary Neuroendocrine Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-25Clinical Trial Results: Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors [Phase 2]
Phase 2 trial results for nab-sirolimus in patients with well-differentiated neuroendocrine tumors (NETs) of the gastrointestinal tract, lun…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors [Phase 2]
This clinical trial update describes a Phase 2 study evaluating Lutetium-177 dotatate in somatostatin receptor-positive advanced pulmonary n…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Surufatinib Combined With Chemo Versus Surufatinib in the Treatment of Pulmonary Neuroendocrine Tumors [Phase 2]
A Phase 2 clinical trial comparing Surufatinib plus chemotherapy versus Surufatinib alone in patients with pulmonary neuroendocrine tumors i…
-
CLINICAL_TRIALS trial_result · 2025-11-04Clinical Trial Update: A Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine Tumors [EARLY_Phase 1]
Early-phase safety study of the radiopharmaceutical 212Pb-VMT-alpha-NET in patients with neuroendocrine tumors is active but not currently r…
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: Open-Label Surufatinib in European Patients With NET [Phase 2]
An open-label Phase 2 trial of surufatinib in European patients with neuroendocrine tumors was terminated, with results posted in 2025.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: 177Lu-PP-F11N for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer. [Phase 1]
Phase 1 clinical trial evaluating the radiopharmaceutical 177Lu-PP-F11N for receptor-targeted therapy and imaging in metastatic medullary th…
-
CLINICAL_TRIALS trial_result · 2025-01-09Clinical Trial Update: Durvalumab (MEDI4736) Plus Tremelimumab for Advanced Neuroendocrine Neoplasms of Gastroenteropancreatic or Lung Origin [Phase 2]
A phase 2 trial evaluating the combination of durvalumab and tremelimumab in advanced gastroenteropancreatic and lung-origin neuroendocrine …
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Phase II Study of Adebrelimab, Chemotherapy, and Apatinib for Advanced Pulmonary Neuroendocrine Tumors [Phase 2]
Phase II study evaluating Adebrelimab plus chemotherapy and Apatinib for advanced pulmonary neuroendocrine tumors; trial status is not yet r…
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors [Phase 2]
A Phase 2 clinical trial is evaluating nab-sirolimus in patients with well-differentiated neuroendocrine tumors of the gastrointestinal trac…
-
CLINICAL_TRIALS research · 2024-05-07Clinical Trial Update: Observational Study on GEP-and Pulm-NET Treated at FPG
An observational clinical trial update describes a study of gastroenteropancreatic and pulmonary neuroendocrine tumors treated at Fondazione…
-
CLINICAL_TRIALS trial_result · 2014-12-30Clinical Trial Update: Safety and Efficacy of RAD001 in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor [Phase 1]
Phase 1 trial assessing safety and preliminary efficacy of RAD001 (everolimus) in Chinese patients with advanced pulmonary neuroendocrine tu…
-
CLINICAL_TRIALS trial_result · 2010-08-04Clinical Trial Update: Safety and Tolerability Profile of RAD001 Daily in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor [Phase 1, Phase 2]
A Phase 1/2 clinical trial update evaluating the safety and tolerability of RAD001 (everolimus) daily in Chinese patients with advanced pulm…